NEWS
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Sven Turkalj
University of Oxford - Oxford / United Kingdom
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 6044499
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Sven Turkalj's MOST POPULAR ARTICLES
1-)
Mechanisms of B cell receptor activation and responses to B cell receptor inhibitors in B cell malignanciesDG Efremov, S Turkalj, L LaurentiCancers 12 (6), 1396, 2020722020
2-)
A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid MalignanciesCA Lachowiez, S Loghavi, Z Zeng, T Tanaka, YJ Kim, H Uryu, S Turkalj, ...Blood cancer discovery 4 (4), 276-293, 2023452023
3-)
Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphomaBK Sasi, C Martines, E Xerxa, F Porro, H Kalkan, R Fazio, S Turkalj, ...Leukemia 33 (10), 2416-2428, 2019362019
4-)
An overview of targeted therapies in acute myeloid leukemiaS Turkalj, FA Radtke, P VyasHemasphere 7 (6), e914, 2023162023
5-)
Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and agingNA Jakobsen, S Turkalj, AGX Zeng, B Stoilova, M Metzner, S Rahmig, ...Cell stem cell 31 (8), 1127-1144. e17, 2024112024
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept